# Vaxcyte, Inc. (PCVX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PCVX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -320.62M | $ -295.42M | $ 116.30M | $ 3.00B |
| 2025 | $ 0 | $ -784.96M | $ -685.29M | $ 228.84M | $ 2.69B |
| 2024 | $ 0 | $ -487.62M | $ -607.71M | $ 71.11M | $ 3.31B |
| 2023 | $ 0 | $ -434.95M | $ -394.30M | $ 29.22M | $ 1.24B |
| 2022 | $ 0 | $ -249.66M | $ -197.11M | $ 17.94M | $ 953.61M |
| 2021 | $ 0 | $ -118.96M | $ -152.09M | $ 16.78M | $ 284.02M |
| 2020 | $ 0 | $ -113.66M | $ -60.87M | $ 0 | $ 345.84M |
| 2019 | $ 0 | $ -69.02M | $ -62.39M | $ 161.0K | $ -106.37M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.04 |
| Liabilities / Eq | 0.12 |
| Current Ratio | 7.49 |

## Other views

- [Metrics](https://sponda.capital/en/PCVX.md)
- [Charts](https://sponda.capital/en/PCVX/charts.md)
- [Compare](https://sponda.capital/en/PCVX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.